Novartis Reports New Data of Kesimpta (ofatumumab) in ALITHIOS Study for Multiple Sclerosis
Shots: Mylan to get exclusive commercialization rights of the product in >100 countries, including Africa, Asia, the Middle East, the Commonwealth of Independent States (CIS) and Latin America. Mylan plans to launch Mylan HIV Self-Test in global markets in 2019 CE-Marked in-vitro HIV rapid diagnostic tests allow individuals to detect presence or absence of HIV […]Read More
